公开(公告)号：US11623911B2

公开(公告)日：2023-04-11

申请号：US16146469

申请日：2018-09-28

申请人： Commonwealth Scientific and Industrial Research Organisation ,  Grains Research and Development Corporation ,  Nuseed Nutritional Australia Pty Ltd

发明人： James Robertson Petrie ,  Surinder Pal Singh ,  Pushkar Shrestha ,  Jason Timothy McAllister ,  Robert Charles de Feyter ,  Malcolm David Devine

IPC分类号： C07C69/587 ,  C12N15/82 ,  A61K36/31 ,  A23D9/00 ,  A61K31/20 ,  A61K31/201 ,  A61K31/202 ,  C11B1/10

摘要： The present invention relates to extracted plant lipid or microbial lipid comprising docosapentaenoic acid, and processes for producing the extracted lipid.

公开(公告)号：US11591540B2

公开(公告)日：2023-02-28

申请号：US16771326

申请日：2018-12-18

申请人： Wageningen Universiteit

发明人： Konstantinos Nikiforidis

IPC分类号： C11B1/10 ,  A23L33/115 ,  A61K8/14 ,  A61K8/92 ,  A61K9/107 ,  A61K36/31 ,  A61K47/44 ,  A61Q19/00 ,  C11B3/00 ,  C11B3/16

摘要： A method for extracting naturally occurring oil bodies (oleosomes) from a material containing naturally occurring oil bodies (oleosomes) includes the steps of dispersing the material containing oleosomes in an aqueous composition to thereby obtain an aqueous dispersion of material containing oleosomes, extracting oleosomes from the aqueous dispersion of material containing oleosomes to thereby obtain a crude oleosome extract and isolating crude oleosomes from the extract by drying the crude oleosome extract. The dried oleosome powder may be used with a personal care product, a pharmaceutical product or a food product.

公开(公告)号：US20230042908A1

公开(公告)日：2023-02-09

申请号：US17961836

申请日：2022-10-07

申请人： Next2Me, LLC

发明人： Ralph L. Peterson ,  Renee D. Williman

IPC分类号： A61K36/296 ,  A61K36/254 ,  A61K36/81 ,  A61K36/258 ,  A61K36/79 ,  A61K36/31 ,  A61K36/74 ,  A61K31/714 ,  A61K31/525 ,  A61K31/51 ,  A61K31/455 ,  A61K31/4415 ,  A61K31/198 ,  A61K31/197 ,  A61K31/05 ,  A61K31/4188 ,  A61K31/519 ,  A61K31/593 ,  A61K31/375

摘要： A biochemical scaffold for regulating mammalian cell function. The biochemical scaffold includes a base liquid medium, a bioenergetic platform and a vibrational platform. The bioenergetic platform includes at least one Krebs cycle modulator and the vibrational platform includes at least one energy signature component, e.g., an herb. The biochemical scaffold is subjected to sequential harmonic oscillation at defined frequency ranges for a defined, predetermined period of time, wherein the energy signature of the energy signature component is imparted to, captured, replicated, and retained by liquid medium, and, when the biochemical scaffold is delivered to and, thus, in communication with biological tissue, the biochemical scaffold induces specific biochemical activities via the resonant transfer of the retained energy signature to the biological tissue and, hence, endogenous cells thereof, the biochemical activities including increased bioavailability of ATP.

公开(公告)号：US20230029361A1

公开(公告)日：2023-01-26

申请号：US17931368

申请日：2022-09-12

申请人： DST Pharma, Inc.

发明人： Lu Wang

IPC分类号： A61K36/70 ,  A23L33/105 ,  A61P31/14 ,  A61K31/353 ,  A61K36/076 ,  A61K36/28 ,  A61K36/282 ,  A61K36/288 ,  A61K36/31 ,  A61K36/36 ,  A61K36/48 ,  A61K36/536 ,  A61K36/68 ,  A61K36/82 ,  A61K45/06

摘要： Fagopyrum dibotyo nutraceuticals and methods of their use are provided. The disclosed F. dibotyo nutraceuticals are useful to improve or increase liver function and to treat liver diseases, especially those caused by viral hepatitis. In some embodiments, the F. dibotyo nutraceuticals also contain supplementary botanical extracts to confer additional health benefits.

公开(公告)号：US11554104B2

公开(公告)日：2023-01-17

申请号：US16639945

申请日：2018-08-20

申请人： The Schepens Eye Research Institute, Inc.

发明人： Joseph B. Ciolino

IPC分类号： A61K31/26 ,  A61K9/00 ,  A61K9/48 ,  A61K36/31 ,  A61K47/10

摘要： The disclosure relates to compositions containing allyl isothiocyanate and methods of use thereof for stimulating tearing in a subject to treat dry eye.

公开(公告)号：US11510960B2

公开(公告)日：2022-11-29

申请号：US16470904

申请日：2017-12-21

申请人： Whiteley Corporation Pty Ltd ,  The University of Sydney

发明人： Theerthankar Das Ashish Kumar ,  Jim Manos ,  Gregory Stuart Whiteley ,  Trevor Owen Glasbey

IPC分类号： A61K36/31 ,  A61K38/06 ,  A61P31/04 ,  A61K31/496 ,  A61K31/7036 ,  A61K38/46 ,  A61K33/18 ,  A61K33/30 ,  A61K47/38 ,  A61K9/00 ,  A61K9/06

摘要： A biofilm disrupting composition for use on chronic wounds comprising (i) at least one biologically acceptable thiol based antioxidant (ii) at least one biofilm disruptor and (iii) at least one biocide. Also disclosed is a process of preparing the composition. Also disclosed is the use of the composition for the manufacture of a medicament for the treatment of a chronic wound, and a method of treating a chronic wound in a patient comprising administering the biofilm disrupting composition.

公开(公告)号：US11484563B2

公开(公告)日：2022-11-01

申请号：US17148441

申请日：2021-01-13

申请人： LifeVantage Corporation

发明人： Brian Dixon ,  Christina Beer ,  Qiana Martinez

IPC分类号： A61K36/9066 ,  A61K36/81 ,  A61K36/82 ,  A61K36/53 ,  A61K36/87 ,  A61K36/63 ,  A61K36/31 ,  A61K31/221 ,  A61K31/352 ,  A61K31/385 ,  A61K31/122 ,  A61K31/198 ,  A61K31/165 ,  A61K31/465 ,  A61K33/34 ,  A61K31/05 ,  A61K36/9062 ,  A61K31/353 ,  A61K9/48 ,  A61P39/06 ,  A61K9/20 ,  A61K9/00 ,  A61K36/28 ,  A61K31/455 ,  A61K31/522 ,  A61K36/68 ,  A61K31/30 ,  A61K31/357 ,  A61K36/22

摘要： Compositions and methods for increasing stress response and improving health and slowing the aging process in a user. A composition includes one or more of a first group consisting of milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric. The composition includes one or more of a second group consisting of acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape. The composition includes one or more of a third group consisting of wasabi, theacrine, copper, nicacin, cysteine, and olive extract.

公开(公告)号：US11484514B2

公开(公告)日：2022-11-01

申请号：US16957432

申请日：2018-12-20

申请人： NUBEBE CO., LTD. ,  HUMAN HERB CO., LTD.

发明人： Young Woo Lim ,  Ji Myeong Ok ,  Woon Ho Lee ,  Young Bin Kim

IPC分类号： A61P3/04 ,  A61K36/346 ,  A61K36/488 ,  A61K36/882 ,  A61K36/49 ,  A61K36/8994 ,  A61K36/31 ,  A61K36/736 ,  A61K36/8945 ,  A61K36/185 ,  A61K47/02 ,  A61K47/46 ,  A61K36/534 ,  A61K36/744 ,  A61K36/538 ,  A61K36/708 ,  A61K33/04 ,  A61K36/64 ,  A61K36/65 ,  A61K31/137 ,  A61K9/19 ,  A61K36/258 ,  A61K36/481 ,  A61K36/284 ,  A61K36/54 ,  A61K36/9068 ,  A61K36/076 ,  A61K36/752 ,  A61K36/725 ,  A61K36/734 ,  A61K36/575 ,  A61K36/884 ,  A61J3/06 ,  A61K9/28 ,  A61K36/17 ,  A61K36/62

摘要： An embodiment of the present invention provides a manufacturing method of an herbal medicinal tablet formulation for treating obesity which is prescribed based on Sasang constitutional medicine, comprises manufacturing a concentrated ephedra powder agent so that an ephedrine content is 3.0-4.0%; determining a weight of the concentrated ephedra powder agent according to each constitution of Sasang constitutional medicine, and manufacturing a side effect-preventing powder agent for each constitution to prevent and suppress side effects according to constitution of Sasang constitutional medicine with respect to the weight of the concentrated ephedra powder agent; mixing the concentrated ephedra powder agent and the side effect-preventing powder agent with a variance of a weight ratio therebetween in consideration of weight, obesity, constitution of Sasang constitutional medicine, and side effects; and tableting the mixture of the prepared ephedra powder agent and side effect-preventing powder agent.

公开(公告)号：US20220184161A1

公开(公告)日：2022-06-16

申请号：US17682694

申请日：2022-02-28

申请人： BASF PLANT SCIENCE COMPANY GMBH

发明人： Toralf Senger ,  Carl Andre

IPC分类号： A61K36/31 ,  C12Q1/6895

摘要： The present invention generally is concerned with the modification of plant lipids containing PUFAs. In this context, the invention is particularly concerned with plants and plant materials for such modifications, wherein the plants preferably are oilseed plants. Regarding plant parts, the invention is particularly concerned with seeds of such plants and preferably seeds of oilseed plants. The invention is also concerned with plant positions obtainable or obtained by the modification method of the invention, and with full stuff of feedstuff comprising such liquid compositions.

公开(公告)号：US20220184108A1

公开(公告)日：2022-06-16

申请号：US17119734

申请日：2020-12-11

申请人： East West Products Corp.

发明人： Steve S. Lee ,  Francis YM Wong ,  Thee Sheng Tan ,  Siew Seng NG

IPC分类号： A61K31/7076 ,  A61K31/455 ,  A61K31/706 ,  A61K31/7004 ,  A61K31/015 ,  A61K31/198 ,  A61K31/52 ,  A61K36/02 ,  A61K31/7032 ,  A61K36/31 ,  A61K9/00 ,  A61K36/87 ,  A61K36/70 ,  A61K36/05 ,  A61K35/748

摘要： There is a composition for maximizing NAD enzyme's health benefits. The composition includes a nucleoside; the nucleoside is adenosine. The nucleoside is a phosphate derivative; wherein the composition includes 1 to 5 percent weight of adenosine. The composition includes a vitamin B3; wherein the vitamin B3 is in the form of niacin, niacinamide, nicotinic acid or nicotinamide. The composition includes 0.1 to 10 percent weight of the Vitamin B3. The composition includes a nicotinamide mononucleotide. The composition includes a stilbene derivative; wherein the composition includes 0.1 to 5 percent weight stilbene derivative.